{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:17:04Z","timestamp":1789503424501,"version":"build-2803163510"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Latent tuberculosis infection (LTBI), affecting nearly one-quarter of the global population, represents a major barrier to Tuberculosis (TB) eradication and a paradigm of chronic infectious disease. Current chemotherapeutic regimens for TB, although effective, are limited by drug resistance, toxicity, and poor adherence, underscoring the urgent need for alternative strategies. In this study, we investigated ARM\u2014a recombinant fusion protein comprising Ag85B, Rv2660c, and MPT70\u2014as a therapeutic vaccine in a murine model of post-exposure\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (\n                    <jats:italic>Mtb<\/jats:italic>\n                    ) infection. ARM immunization elicited robust CD4+ T cell responses, with a higher frequency of polyfunctional T cells producing IFN-\u03b3, and TNF-\u03b1 compared to the classical BCG vaccine. Critically, ARM also induced strong humoral immunity, marked by elevated\n                    <jats:italic>Mtb<\/jats:italic>\n                    - and ARM-specific IgG levels that enhanced Fc\u03b3R-dependent phagocytosis, phagosome\u2013lysosome fusion, and intracellular bacterial clearance. ARM-treated mice exhibited reduced pulmonary pathology, improved weight recovery, and superior control of bacterial burden. These findings demonstrate the potential of therapeutic vaccination to mobilize both cellular and antibody-mediated immunity in controlling\n                    <jats:italic>Mtb<\/jats:italic>\n                    infection and offer a broader immunological strategy for managing chronic infectious diseases. ARM represents a promising candidate for post-exposure TB vaccination, with potential to enhance bacterial clearance and reduce disease progression in high-burden populations.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1624923","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:34:20Z","timestamp":1755149660000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic vaccination with the Ag85B-Rv2660c-MPT70 fusion protein enhances Mycobacterium tuberculosis H37Ra clearance in post-exposure mice"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhiming","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangshan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"B1","volume-title":"World Health Organization Global Tuberculosis Report","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The Global Burden of Latent Tuberculosis Infection: A Re-Estimation Using Mathematical Modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40779-023-00490-8","article-title":"From Immunology to Artificial Intelligence: Revolutionizing Latent Tuberculosis Infection Diagnosis with Machine Learning","volume":"10","author":"Li","year":"2023","journal-title":"Mil Med Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium Tuberculosis Infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and Lung Damage: From Epidemiology to Pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An Official Ats Statement: Hepatotoxicity of Antituberculosis Therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.072","article-title":"Preferred Product Characteristics for Therapeutic Vaccines to Improve Tuberculosis Treatment Outcomes: Key Considerations from World Health Organization Consultations","volume":"38","author":"Vekemans","year":"2020","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.878471","article-title":"Therapeutic Vaccines for Tuberculosis: An Overview","volume":"13","author":"Bouzeyen","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis425","article-title":"Therapeutic Immunization against Mycobacterium Tuberculosis Is an Effective Adjunct to Antibiotic Treatment","volume":"207","author":"Coler","year":"2013","journal-title":"J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2018.08.004","article-title":"(Mip) Immunotherapy in Reducing the Duration of Standard Chemotherapy against Tuberculosis","volume":"65","author":"Chahar","year":"2018","journal-title":"Indian J Tuberc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2015.01.018","article-title":"The History of Tuberculosis Management in Sweden","volume":"32","author":"Wallstedt","year":"2015","journal-title":"Int J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.healthplace.2010.08.018","article-title":"Landscape and Children\u2019s Health: Old Natures and New Challenges for the Preventorium","volume":"17","author":"Grose","year":"2011","journal-title":"Health Place"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature09247","article-title":"An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0966-842x(98)01216-5","article-title":"Mechanisms of Latency in Mycobacterium Tuberculosis","volume":"6","author":"Parrish","year":"1998","journal-title":"Trends Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e73230","DOI":"10.1371\/journal.pone.0073230","article-title":"A Helicopter Perspective on Tb Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into Tb Pathogenesis","volume":"8","author":"Joosten","year":"2013","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The Immune Response in Tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct Phases of Blood Gene Expression Pattern through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response","volume":"207","author":"Cliff","year":"2013","journal-title":"J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e87499","DOI":"10.1172\/jci.insight.87499","article-title":"Polyfunctional and Ifn-\u0393 Monofunctional Human Cd4(+) T Cell Populations Are Molecularly Distinct","volume":"2","author":"Burel","year":"2017","journal-title":"JCI Insight"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1004603","DOI":"10.1371\/journal.ppat.1004603","article-title":"Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-Inflammatory Cytokines Is Associated with Sterilization","volume":"11","author":"Gideon","year":"2015","journal-title":"PLoS Pathog"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor Necrosis Factor-Alpha Is Required in the Protective Immune Response against Mycobacterium Tuberculosis in Mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.12.1847","article-title":"Alphabeta T Cell Receptor-Positive Cells and Interferon-Gamma, but Not Inducible Nitric Oxide Synthase, Are Critical for Granuloma Necrosis in a Mouse Model of Mycobacteria-Induced Pulmonary Immunopathology","volume":"194","author":"Ehlers","year":"2001","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.042531","article-title":"Immunological Control of Tuberculosis: Role of Tumour Necrosis Factor and More","volume":"64","author":"Stenger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0028-0","article-title":"Antibodies and Tuberculosis: Finally Coming of Age","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41467-021-20930-0","article-title":"Human Antibodies Targeting a Mycobacterium Transporter Protein Mediate Protection against Tuberculosis","volume":"12","author":"Watson","year":"2021","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/35084083","article-title":"The Heparin-Binding Haemagglutinin of M. Tuberculosis Is Required for Extrapulmonary Dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive Protection with Immunoglobulin a Antibodies against Tuberculous Early Infection of the Lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15688","article-title":"A Mab Recognizing a Surface Antigen of Mycobacterium Tuberculosis Enhances Host Survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A Mycobacterial Lipoarabinomannan Specific Monoclonal Antibody and Its F(Ab\u2019) Fragment Prolong Survival of Mice Infected with Mycobacterium Tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003189","article-title":"A Novel Human Iga Monoclonal Antibody Protects against Tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2008.09.001","article-title":"Prevention of the Post-Chemotherapy Relapse of Tuberculous Infection by Combined Immunotherapy","volume":"89","author":"Buccheri","year":"2009","journal-title":"Tuberc (Edinb)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636764","article-title":"Il-4 Depletion Enhances Host Resistance and Passive Iga Protection against Tuberculosis Infection in Balb\/C Mice","volume":"37","author":"Buccheri","year":"2007","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2285","article-title":"A Multistage Tuberculosis Vaccine That Confers Efficient Protection before and after Exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/pharmaceutics16070857","article-title":"Tb\/Flu-06e Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis","volume":"16","author":"Shurygina","year":"2024","journal-title":"Pharmaceutics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X2024e13409","article-title":"Ag85b with C-Di-Amp as Mucosal Adjuvant Showed Immunotherapeutic Effects on Persistent Mycobacterium Tuberculosis Infection in Mice","volume":"57","author":"Liang","year":"2024","journal-title":"Braz J Med Biol Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1038\/s41467-021-27029-6","article-title":"A Phase I\/Ii Randomized Trial of H56:Ic31 Vaccination and Adjunctive Cyclooxygenase-2-Inhibitor Treatment in Tuberculosis Patients","volume":"12","author":"Jenum","year":"2021","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201802-0366OC","article-title":"Dose Optimization of H56:Ic31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-Controlled, Dose-Selection Trial","volume":"199","author":"Suliman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(20)30319-2","article-title":"Safety and Immunogenicity of the Adjunct Therapeutic Vaccine Id93\u2008+\u2008Gla-Se in Adults Who Have Completed Treatment for Tuberculosis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2a Trial","volume":"9","author":"Day","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(19)30625-5","article-title":"The Status of Tuberculosis Vaccine Development","volume":"20","author":"Schrager","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.12688\/f1000research.16521.2","article-title":"Research and Development of New Tuberculosis Vaccines: A Review","volume":"7","author":"Schrager","year":"2018","journal-title":"F1000Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1205769","article-title":"Systematic Review of Mathematical Models Exploring the Epidemiological Impact of Future Tb Vaccines","volume":"12","author":"Harris","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4607","article-title":"Potential Impact of Tuberculosis Vaccines in China, South Africa, and India","volume":"12","author":"Harris","year":"2020","journal-title":"Sci Transl Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(23)00045-1","article-title":"The Impact of Alternative Delivery Strategies for Novel Tuberculosis Vaccines in Low-Income and Middle-Income Countries: A Modelling Study","volume":"11","author":"Clark","year":"2023","journal-title":"Lancet Glob Health"},{"key":"B44","volume-title":"An Investment Case for New Tuberculosis Vaccines","year":"2022"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/epirev\/mxz014","article-title":"Postexposure Effects of Vaccines on Infectious Diseases","volume":"41","author":"Gallagher","year":"2019","journal-title":"Epidemiol Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.009","article-title":"Bcg Vaccine: Who Position Paper, February 2018 - Recommendations","volume":"36","author":"World Health","year":"2018","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit790","article-title":"Protection by Bcg Vaccine against Tuberculosis: A Systematic Review of Randomized Controlled Trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-Human Trial of the Post-Exposure Tuberculosis Vaccine H56:Ic31 in Mycobacterium Tuberculosis Infected and Non-Infected Healthy Adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a Nutrient Starvation Model of Mycobacterium Tuberculosis Persistence by Gene and Protein Expression Profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol Microbiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2014.982167","article-title":"Latency-Associated Protein Rv2660c of Mycobacterium Tuberculosis Augments Expression of Proinflammatory Cytokines in Human Macrophages by Interacting with Tlr2","volume":"47","author":"Yihao","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2335-8","article-title":"Mycobacterium Tuberculosis Dormancy-Associated Antigen of Rv2660c Induces Stronger Immune Response in Latent Mycobacterium Tuberculosis Infection Than That in Active Tuberculosis in a Chinese Population","volume":"34","author":"He","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0122560","DOI":"10.1371\/journal.pone.0122560","article-title":"Protection against Mycobacterium Tuberculosis Infection Offered by a New Multistage Subunit Vaccine Correlates with Increased Number of Ifn-\u0393+ Il-2+ Cd4+ and Ifn-\u0393+ Cd8+ T Cells","volume":"10","author":"Wang","year":"2015","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","article-title":"A Mycobacterium Tuberculosis-Specific Subunit Vaccine That Provides Synergistic Immunity Upon Co-Administration with Bacillus Calmette-Gu\u00e9rin","volume":"12","author":"Woodworth","year":"2021","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/jb.171.10.5756-5758.1989","article-title":"Crystalline Cell Surface Layer of Mycobacterium Bovis Bcg","volume":"171","author":"Lounatmaa","year":"1989","journal-title":"J Bacteriol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200700528","article-title":"Membrane and Membrane-Associated Proteins in Triton X-114 Extracts of Mycobacterium Bovis Bcg Identified Using a Combination of Gel-Based and Gel-Free Fractionation Strategies","volume":"8","author":"M\u00e5len","year":"2008","journal-title":"Proteomics"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2009.02256.x","article-title":"Mpb70 and Mpb83\u2013Major Antigens of Mycobacterium Bovis","volume":"69","author":"Wiker","year":"2009","journal-title":"Scand J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1430808","article-title":"Recombinant Protein Ag85b-Rv2660c-Mpt70 Promotes Quality of Bcg-Induced Immune Response against Mycobacterium Tuberculosis H37ra","volume":"16","author":"Ouyang","year":"2025","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0153523","DOI":"10.1128\/mbio.01535-23","article-title":"Herp Regulates Intracellular Survival of Mycobacterium Tuberculosis H37ra in Macrophages by Regulating Reactive Oxygen Species-Mediated Autophagy","volume":"14","author":"Son","year":"2023","journal-title":"mBio"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01647","article-title":"Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium Tuberculosis","volume":"66","author":"Li","year":"2023","journal-title":"J Med Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2024.102479","article-title":"The Use of Mycobacterium Tuberculosis H37ra-Infected Immunocompetent Mice as an in Vivo Model of Persisters","volume":"145","author":"Kumari","year":"2024","journal-title":"Tuberc (Edinb)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.871135","article-title":"Cyclic-Di-Amp Phosphodiesterase Elicits Protective Immune Responses against Mycobacterium Tuberculosis H37ra Infection in Mice","volume":"12","author":"Lu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1992.tb02045.x","article-title":"Definition and Application of a Histopathological Scoring Scheme for an Animal Model of Acute Mycoplasma Pneumoniae Pulmonary Infection","volume":"36","author":"Cimolai","year":"1992","journal-title":"Microbiol Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of Human Antibodies to Arabinomannan with Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1172\/jci128459","article-title":"Capsular Glycan Recognition Provides Antibody-Mediated Immunity against Tuberculosis","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27034","article-title":"Immunogenicity and Protective Efficacy of Ag85a and Truncation of Psts1 Fusion Protein Vaccines against Tuberculosis","volume":"10","author":"Zeng","year":"2024","journal-title":"Heliyon"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2018.12.003","article-title":"Several Routes to the Same Destination: Inhibition of Phagosome-Lysosome Fusion by Mycobacterium Tuberculosis","volume":"357","author":"Carranza","year":"2019","journal-title":"Am J Med Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1002\/mco2.419","article-title":"Mycobacterium Tuberculosis: Immune Response, Biomarkers, and Therapeutic Intervention","volume":"5","author":"Zhuang","year":"2024","journal-title":"MedComm (2020)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0174-z","article-title":"Moving Tuberculosis Vaccines from Theory to Practice","volume":"19","author":"Andersen","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxq010","article-title":"Suppressed Induction of Mycobacterial Antigen-Specific Th1-Type Cd4+ T Cells in the Lung after Pulmonary Mycobacterial Infection","volume":"22","author":"Yahagi","year":"2010","journal-title":"Int Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.10.004","article-title":"Il-17 and Th17 Cells in Tuberculosis","volume":"21","author":"Torrado","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/jci142014","article-title":"Tissue-Resident-Like Cd4+ T Cells Secreting Il-17 Control Mycobacterium Tuberculosis in the Human Lung","volume":"131","author":"Ogongo","year":"2021","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.02.008","article-title":"The Synapse and Cytolytic Machinery of Cytotoxic T Cells","volume":"22","author":"Jenkins","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2020.102021","article-title":"Tuberculosis Vaccination Needs to Avoid \u2018Decoy\u2019 Immune Reactions","volume":"126","author":"Ivanyi","year":"2021","journal-title":"Tuberc (Edinb)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00410-0","article-title":"The Role of Igg Fc Receptors in Antibody-Dependent Enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-126029","article-title":"Fc Gamma R-Stimulated Activation of the Nadph Oxidase: Phosphoinositide-Binding Protein P40phox Regulates Nadph Oxidase Activity after Enzyme Assembly on the Phagosome","volume":"112","author":"Tian","year":"2008","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801717105","article-title":"Dependence of Antibody-Mediated Presentation of Antigen on Fcrn","volume":"105","author":"Qiao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4103\/ijmy.ijmy_33_18","article-title":"Mycobacterium Tuberculosis Strains H37ra and H37rv Have Equivalent Minimum Inhibitory Concentrations to Most Antituberculosis Drugs","volume":"7","author":"Heinrichs","year":"2018","journal-title":"Int J Mycobacteriol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01298","article-title":"Activation of M1 Macrophages in Response to Recombinant Tb Vaccines with Enhanced Antimycobacterial Activity","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018556","article-title":"Mouse Model of Tuberculosis","volume":"5","author":"Cooper","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00419.x","article-title":"Resistance Ranking of Some Common Inbred Mouse Strains to Mycobacterium Tuberculosis and Relationship to Major Histocompatibility Complex Haplotype and Nramp1 Genotype","volume":"93","author":"Medina","year":"1998","journal-title":"Immunology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1128\/iai.57.6.1719-1724.1989","article-title":"Mechanisms of Recrudescence of Mycobacterium Bovis Bcg Infection in Mice","volume":"57","author":"Cox","year":"1989","journal-title":"Infect Immun"},{"key":"B82","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1074\/mcp.RA120.002314","article-title":"Antibody Binding Epitope Mapping (Abmap) of Hundred Antibodies in a Single Run","volume":"20","author":"Qi","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106639","article-title":"Hybridoma Technology a Versatile Method for Isolation of Monoclonal Antibodies, Its Applicability across Species, Limitations, Advancement and Future Perspectives","volume":"85","author":"Parray","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/tan.14781","article-title":"Clinical Utility of Serial Serum Dilutions for Hla Antibody Interpretation","volume":"100","author":"Tambur","year":"2022","journal-title":"Hla"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1624923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:34:21Z","timestamp":1755149661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1624923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":84,"alternative-id":["10.3389\/fimmu.2025.1624923"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1624923","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"article-number":"1624923"}}